Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
News|Videos|November 1, 2023
Waleria Healthtech’s CEO, Komal Baldwa, discusses the company’s new shatavari ingredient and the women’s health in Ayurveda
Waleria Healthtech’s CEO, Komal Baldwa, discusses the company’s new shatavari ingredient, aspurus, and applying the principles of Ayurveda in promoting women's health in the modern dietary supplement market.
Advertisement
Waleria Healthtech’s CEO, Komal Baldwa, spoke with Nutritional Outlook's editor Sebastian Krawiec at this year's SupplySide West about the company’s new shatavari ingredient, aspurus, and applying the principles of Ayurveda in promoting women's health in the modern dietary supplement market.
Advertisement
Related to this article
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.
DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.
Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
Advertisement
Advertisement